Biologics APIs

Mar 06, 2018
By Pharmaceutical Technology Editors
The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.
Feb 20, 2018
By Pharmaceutical Technology Editors
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.
Feb 07, 2018
By Pharmaceutical Technology Editors
Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.
Feb 02, 2018
Pharmaceutical Technology
Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.
Jan 26, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Comecar will provide cell culture equipment for biopharmaceutical company CO.DON AG's new production site in Leipzig, Germany.
Jan 26, 2018
Pharmaceutical Technology's In the Lab eNewsletter
By Pharmaceutical Technology Editors
Corning will feature its 3D bioprinting technology and tools to support 3D cell culture at booth #1029 during the SLAS 2018 conference on Feb. 3-7, 2018 in San Diego, CA.
Jan 12, 2018
By Pharmaceutical Technology Editors
The acquisition, valued at EUR 520 million (US$631 million), would expand Takeda’s late-stage pipeline in gastroenterology and would extend an already existing collaboration between the two companies.
Jan 08, 2018
Graham Reynolds, vice-president and general manager, Global Biologics at West Pharmaceutical Services, Inc., shares insights on key considerations when developing a biologic drug product in a prefilled syringe.
Jan 05, 2018
By Pharmaceutical Technology Editors
The companies aim to discover and develop locked nucleic acid oligonucleotides as orally available therapies for treating inflammatory bowel diseases.
Jan 05, 2018
By Pharmaceutical Technology Editors
The companies aim to develop a potential zinc finger protein transcription factor-based gene therapy for treating Lou Gehrig’s disease.
native1_300x100
lorem ipsum